# Drug-Drug Interaction Study With Aricept® (Donepezil)

> **NCT01042314** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 18 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** BMS-708163

## Key facts

- **NCT ID:** NCT01042314
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042314, "Drug-Drug Interaction Study With Aricept® (Donepezil)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01042314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*